The microbiome–systemic diseases connection

Oral Diseases

Volumn 22, Issue 8, 2016, Pages 719-734

  van der Meulen, T A ^a   Harmsen, H J M ^a   Bootsma, H ^a   Spijkervet, F K L ^a   Kroese, F G M ^a   Vissink, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

autoimmune disease; autoinflammatory diseases; bacteria; immunology; immunopathology; inflammatory diseases; microbiology; pathogenesis; rheumatology

Indexed keywords

AUTOANTIBODY; CYTOKINE; PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; DYSBIOSIS; HUMAN; INTESTINE; INTESTINE MUCOSA PERMEABILITY; JOINT; LYMPHOCYTE; MICROBIOME; MOUTH CAVITY; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SALIVARY GLAND; SJOEGREN SYNDROME; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 85027930713     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12472     Document Type: Article

References (182)

1. Aletaha D, Neogi T, Silman AJ et al (2010). 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569–2581.
2. Almståhl A, Wikström M, Stenberg I, Jakobsson A, Fagerberg-Mohlin B (2003). Oral microbiota associated with hyposalivation of different origins. Oral Microbiol Immunol 18: 1–8.
3. Amara K, Steen J, Murray F et al (2013). Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 210: 445–455.
4. Apperloo-Renkema HZ, Bootsma H, Mulder BI, Kallenberg CG, van der Waaij D (1994). Host-microflora interaction in systemic lupus erythematosus (SLE): colonization resistance of the indigenous bacteria of the intestinal tract. Epidemiol Infect 112: 367–373.
5. Arendorf TM, Walker DM (1980). The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 25: 1–10.
6. Arpaia N, Campbell C, Fan X et al (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451–455.
7. Arron ST, Dimon MT, Li Z et al (2014). High rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis. J Invest Dermatol 134: 1–8.
8. Atarashi K, Tanoue T, Oshima K et al (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232–236.
9. Atuma C, Strugala V, Allen A, Holm L (2001). The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 280: G922–G929.
10. Ball RJ, Avenell A, Aucott L, Hanlon P, Vickers MA (2015). Systematic review and meta-analysis of the sero-epidemiological association between Epstein–Barr virus and rheumatoid arthritis. Arthritis Res Ther 17: 274.
11. Barrera MJ, Bahamondes V, Sepúlveda D et al (2013). Sjögren's syndrome and the epithelial target: a comprehensive review. J Autoimmun 42: 7–18.
12. Bauer H, Horowitz R, Levenson S, Popper H (1963). The response of the lymphatic tissue to the microbial flora. Am J Pathol 42: 471–483.
13. Belkaid Y, Hand TW (2014). Role of the microbiota in immunity and inflammation. Cell 157: 121–141.
14. Belkaid Y, Naik S (2013). Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 14: 646–653.
15. Benckert J, Schmolka N, Kreschel C et al (2011). The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest 121: 1946–1955.
16. Bikel S, Valdez-Lara A, Cornejo-Granados F et al (2015). Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome. Comput Struct Biotechnol J 13: 390–401.
17. Bogdanos DP, Smyk DS, Rigopoulou EI et al (2012). Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 38: J156–J169.
18. Brandtzaeg P (2013). Secretory immunity with special reference to the oral cavity. J Oral Microbiol 5: 1–24.
19. Brandtzaeg P, Johansen F-E (2005). Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 206: 32–63.
20. Brandtzaeg P, Farstad IN, Johansen F-E, Morton HC, Norderhaug IN, Yamanaka T (1999). The B-cell system of human mucosae and exocrine glands. Immunol Rev 171: 45–87.
21. Brandtzaeg P, Kiyono H, Pabst R, Russell MW (2008). Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 1: 31–37.
22. Bruno MEC, Rogier EW, Frantz AL, Stefka AT, Thompson SN, Kaetzel CS (2010). Regulation of the polymeric immunoglobulin receptor in intestinal epithelial cells by Enterobacteriaceae: implications for mucosal homeostasis. Immunol Invest 39: 356–382.
23. Cárdenas-Roldán J, Rojas-Villarraga A, Anaya J (2013). How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med 11: 73.
24. Castaño-Rodríguez N, Diaz-Gallo L-M, Pineda-Tamayo R, Rojas-Villarraga A, Anaya J-M (2008). Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun Rev 7: 322–330.
25. Cénit MC, Matzaraki V, Tigchelaar EF, Zhernakova A (2014). Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim Biophys Acta 1842: 1981–1992.
26. Cerf-Bensussan N, Gaboriau-Routhiau V (2010). The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10: 735–744.
27. Cheroutre H, Lambolez F, Mucida D (2011). The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11: 445–456.
28. Christensen LB, Petersen PE, Thorn JJ, Schiødt M (2001). Dental caries and dental health behavior of patients with primary Sjögren syndrome. Acta Odontol Scand 59: 116–120.
29. Coombes JL, Powrie F (2008). Dendritic cells in intestinal immune regulation. Nat Rev Immunol 8: 435–446.
30. Cornec D, Saraux A, Jousse-Joulin S et al (2015). The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review. Clin Rev Allergy Immunol 49: 278–287.
31. Croia C, Astorri E, Murray-Brown W et al (2014). Implication of Epstein–Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome. Arthritis Rheumatol 66: 2545–2557.
32. Dallas SD, Rolfe RD (1998). Binding of Clostridium difficile toxin A to human milk secretory component. J Med Microbiol 47: 879–888.
33. Danchenko N, Satia J, Anthony MS (2006). Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15: 308–318.
34. David LA, Maurice CF, Carmody RN et al (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559–563.
35. Deapen D, Escalante A, Weinrib L et al (1992). A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35: 311–318.
36. Delima AJ, Van Dyke TE (2003). Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 31: 55–76.
37. Dewhirst FE, Chen T, Izard J et al (2010). The human oral microbiome. J Bacteriol 192: 5002–5017.
38. Dominguez-Bello MG, Costello EK, Contreras M et al (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107: 11971–11975.
39. Eckburg PB, Bik EM, Bernstein CN et al (2005). Diversity of the human intestinal microbial flora. Science 308: 1635–1638.
40. Ege MJ, Mayer M, Normand A-C et al (2011). Exposure to environmental microorganisms and childhood asthma. N Engl J Med 364: 701–709.
41. Fábián TK, Hermann P, Beck A, Fejérdy P, Fábián G (2012). Salivary defense proteins: their network and role in innate and acquired oral immunity. Int J Mol Sci 13: 4295–4320.
42. Faith JJ, Ahern PP, Ridaura VK, Cheng J, Gordon JI (2014). Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 6: 1–13.
43. Forbes SJ, Eschmann M, Mantis NJ (2008). Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infect Immun 76: 4137–4144.
44. Forbes SJ, Bumpus T, McCarthy EA, Corthésy B, Mantis NJ (2011). Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. MBio 2: 9–12.
45. Frankenfeld CL, Atkinson C, Thomas WK et al (2004). Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med (Maywood) 229: 902–913.
46. Franzosa EA, Hsu T, Sirota-Madi A et al (2015a). Sequencing and beyond: integrating molecular “omics” for microbial community profiling. Nat Rev Microbiol 13: 360–372.
47. Franzosa EA, Huang K, Meadow JF et al (2015b). Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci 112: E2930–E2938.
48. Gabarrini G, de Smit M, Westra J et al (2015). The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis. Sci Rep 5: 13936.
49. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E et al (2009). The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31: 677–689.
50. Gill SR, Pop M, Deboy RT et al (2006). Metagenomic analysis of the human distal gut microbiome. Science 312: 1355–1359.
51. Goldblatt F, O'Neill SG (2013). Clinical aspects of autoimmune rheumatic diseases. Lancet 382: 797–808.
52. González S, Sung H, Sepúlveda D, González M, Molina C (2014). Oral manifestations and their treatment in Sjögren's syndrome. Oral Dis 20: 153–161.
53. Goodrich JK, Waters JL, Poole AC et al (2014). Human genetics shape the gut microbiome. Cell 159: 789–799.
54. Gottenberg J, Cagnard N, Lucchesi C et al (2006). Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci 103: 2770–2775.
55. Grada A, Weinbrecht K (2013). Next-generation sequencing: methodology and application. J Invest Dermatol 133: e11–e14.
56. Gullberg R (1978). Possible role of alterations of the intestinal flora in rheumatoid arthritis. Rheumatology (Oxford) XVII(Suppl.): 5–10.
57. Hamady M, Knight R (2009). Microbial community profiling for human microbiome projects: tools, techniques, and challenges. Genome Res 19: 1141–1152.
58. Hanlon P, Avenell A, Aucott L, Vickers MA (2014). Systematic review and meta-analysis of the sero-epidemiological association between Epstein–Barr virus and systemic lupus erythematosus. Arthritis Res Ther 16: R3.
59. Harley JB, Alarcón-Riquelme ME, Criswell LA et al (2008). Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40: 204–210.
60. Helander HF, Fändriks L (2014). Surface area of the digestive tract – revisited. Scand J Gastroenterol 49: 681–689.
61. Hevia A, Milani C, López P et al (2014). Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 5: e01548-14.
62. Higgs BW, Liu Z, White B et al (2011). Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 70: 2029–2036.
63. van't Hof W, Veerman ECI, Nieuw Amerongen AV, Ligtenberg AJM (2014). Antimicrobial defense systems in saliva. Monogr Oral Sci 24: 40–51.
64. Hooper LV, Littman DR, Macpherson AJ (2012). Interactions between the microbiota and the immune system. Science 336: 1268–1273.
65. Hovav A-H (2014). Dendritic cells of the oral mucosa. Mucosal Immunol 7: 27–37.
66. Huttenhower C, Gevers D, Knight R et al (2012). Structure, function and diversity of the healthy human microbiome. Nature 486: 207–214.
67. Huttenhower C, Kostic AD, Xavier RJ (2014). Inflammatory bowel disease as a model for translating the microbiome. Immunity 40: 843–854.
68. Imhann F, Bonder MJ, Vich Vila A et al (2015). Proton pump inhibitors affect the gut microbiome. Gut doi: 10.1136/gutjnl-2015-310376.
69. Ivanov II, Atarashi K, Manel N et al (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485–498.
70. Ivashkiv LB, Donlin LT (2014). Regulation of type I interferon responses. Nat Rev Immunol 14: 36–49.
71. Iwasaki A (2007). Mucosal dendritic cells. Annu Rev Immunol 25: 381–418.
72. 1 mice. Clin Exp Immunol 181: 323–337.
73. Jonsson R, Theander E, Sjöström B, Brokstad K, Henriksson G (2013). Autoantibodies present before symptom onset in primary Sjögren syndrome. J Am Med Assoc 310: 1854–1855.
74. Kaetzel CS (2014). Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism. Immunol Lett 162: 10–21.
75. Kalk WWI, Vissink A, Spijkervet FKL, Bootsma H, Kallenberg CGM, Amerongen AVN (2001). Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 60: 1110–1116.
76. Koenig JE, Spor A, Scalfone N et al (2011). Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108(Suppl.): 4578–4585.
77. Kostic AD, Gevers D, Siljander H et al (2015). The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17: 260–273.
78. Koziel J, Mydel P, Potempa J (2014). The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep 16: 408.
79. Kroese FGM, Abdulahad WH, Haacke E, Bos NA, Vissink A, Bootsma H (2014). B-cell hyperactivity in primary Sjögren's syndrome. Expert Rev Clin Immunol 10: 483–499.
80. Kuo C-F, Grainge MJ, Valdes AM et al (2015). Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern Med 175: 1518–1526.
81. Kvale D, Brandtzaeg P (1995). Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 36: 737–742.
82. Kweon MN (2011). Sublingual mucosa: a new vaccination route for systemic and mucosal immunity. Cytokine 54: 1–5.
83. Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG (2013). A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun 51: 67–74.
84. Lerner A, Matthias T (2015). Rheumatoid arthritis–celiac disease relationship: joints get that gut feeling. Autoimmun Rev 14: 1038–1047.
85. Lessard CJ, Ice JA, Maier-Moore J, Montgomery CG, Scofield H, Moser KL (2012). Genetics, genomics, and proteomics of Sjögren's syndrome. In: Ramos-Casals M, Stone JH, Moutsopoulos HM eds. Sjögren's syndrome – Diagnosis and Therapeutics. 1st edn. Springer: London, pp. 2.11–2.31.
86. Lessard CJ, Li H, Adrianto I et al (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 45: 1284–1292.
87. Leung KCM, Leung WK, McMillan AS (2007). Supra-gingival microbiota in Sjögren's syndrome. Clin Oral Investig 11: 415–423.
88. Leung KCM, McMillan AS, Cheung BPK, Leung WK (2008). Sjögren's syndrome sufferers have increased oral yeast levels despite regular dental care. Oral Dis 14: 163–173.
89. Lewis K, Lutgendorff F, Phan V, Söderholm JD, Sherman PM, McKay DM (2010). Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 16: 1138–1148.
90. Li Y, Ismail AI, Ge Y, Tellez M, Sohn W (2007). Similarity of bacterial populations in saliva from African-American mother-child dyads. J Clin Microbiol 45: 3082–3085.
91. Liang Y, Yang Z, Qin B, Zhong R (2014). Primary Sjögren's syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis 73: 1151–1156.
92. Lin Z, Bei J-X, Shen M et al (2011). A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet 44: 73–77.
93. Lin X, Rui K, Deng J et al (2014). Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Ann Rheum Dis 74: 1302–1310.
94. Lipsky PE (2001). Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2: 764–766.
95. Liu LM, MacPherson GG (1995). Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. Immunology 85: 88–93.
96. Loss G, Depner M, Ulfman LH et al (2015). Consumption of unprocessed cow's milk protects infants from common respiratory infections. J Allergy Clin Immunol 135: 56–62.
97. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012). Diversity, stability and resilience of the human gut microbiota. Nature 489: 220–230.
98. Lu M-C, Jheng C-H, Tsai T-Y, Koo M, Lai N-S (2014). Increased dental visits in patients prior to diagnosis of primary Sjögren's syndrome: a population-based study in Taiwan. Rheumatol Int 34: 1555–1561.
99. Lugonja B, Yeo L, Milward M et al (2016). Periodontitis prevalence and serum antibody reactivity to periodontal bacteria in primary Sjögren's syndrome: a pilot study. J Clin Periodontol 43: 26–33.
100. Luzuriaga K, Sullivan JL (2011). Infectious mononucleosis. N Engl J Med 362: 1993–2000.
101. Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A (2013). Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol 6: 666–677.
102. Maccaferri S, Biagi E, Brigidi P (2011). Metagenomics: key to human gut microbiota. Dig Dis 29: 525–530.
103. MacFarlane TW, Mason DK (1974). Changes in the oral flora in Sjogren's syndrome. J Clin Pathol 27: 416–419.
104. MacGregor AJ, Snieder H, Rigby AS et al (2000). Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43: 30–37.
105. Manichanh C, Borruel N, Casellas F, Guarner F (2012). The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9: 599–608.
106. Mansson I, Colldahl H (1965). The intestinal flora in patients with bronchial asthma and rheumatoid arthritis. Allergy 20: 94–104.
107. Mantis NJ, Rol N, Corthésy B (2011). Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4: 603–611.
108. Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, Rizo-Rodríguez JC, Little JW, Loyola-Rodríguez JP (2009). Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 36: 1004–1010.
109. Martinez-Medina M, Denizot J, Dreux N et al (2014). Western diet induces dysbiosis with increased E. coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 63: 116–124.
110. Mathews SA, Kurien BT, Scofield RH (2008). Oral manifestations of Sjögren's syndrome. J Dent Res 87: 308–318.
111. McLean MH, Dieguez D, Miller LM, Young HA (2014). Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut 64: 332–341.
112. Moingeon P (2013). Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract 1: 228–241.
113. Montgomery AB, Kopec J, Shrestha L et al (2015). Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis. Ann Rheum Dis doi: 10.1136/annrheumdis-2015-207656.
114. Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E (2014). Frequent involvement of central nervous system in primary Sjögren syndrome. Rheumatol Int 35: 289–294.
115. Morgan XC, Tickle TL, Sokol H et al (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13: R79.
116. Mucida D, Park Y, Kim G et al (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256–260.
117. Mukherjee S, Hooper LV (2014). Review antimicrobial defense of the intestine. Immunity 42: 28–39.
118. Nave H, Gebert A, Pabst R (2001). Morphology and immunology of the human palatine tonsil. Anat Embryol (Berl) 204: 367–373.
119. Nesse W, Dijkstra PU, Abbas F et al (2010). Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol 81: 1622–1628.
120. Nishimura M, Miyajima S, Okada N (2000). Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren's syndrome. J Dermatol 27: 450–452.
121. Noble JA, Erlich HA (2012). Genetics of type 1 diabetes. Cold Spring Harb Perspect Med 2: a007732.
122. Okada Y, Wu D, Trynka G et al (2014). Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506: 376–381.
123. Olhagen B, Månsson I (1968). Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases. Acta Med Scand 184: 395–402.
124. Olsen NJ, Karp DR (2013). Autoantibodies and SLE—the threshold for disease. Nat Rev Rheumatol 10: 181–186.
125. Olszak T, An D, Zeissig S et al (2012). Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336: 489–493.
126. Petersen C, Round JL (2014). Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16: 1024–1033.
127. Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic J (2009). Metagenomic pyrosequencing and microbial identification. Clin Chem 55: 856–866.
128. Pollard M, Sharon N (1970). Responses of the Peyer's patches in germ-free mice to antigenic stimulation. Infect Immun 2: 96–100.
129. Qin J, Li R, Raes J et al (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59–65.
130. Qin B, Wang J, Yang Z et al (2014). Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74: 1983–1989.
131. Qiu X, Zhang M, Yang X, Hong N, Yu C (2013). Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohns Colitis 7: e558–e568.
132. Quiding M (1991). Intestinal immune responses in humans: oral cholera vaccination induces strong intestinal antibody responses and interferon-[gamma] production and evokes immunological memory. J Clin Invest 88: 143–148.
133. Quirke A-M, Lugli EB, Wegner N et al (2014). Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis 73: 263–269.
134. Raychaudhuri S, Sandor C, Stahl EA et al (2012). Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44: 291–296.
135. Rey J, Garin N, Spertini F, Corthésy B (2004). Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol 172: 3026–3033.
136. Riedler J, Braun-Fahrländer C, Eder W et al (2001). Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358: 1129–1133.
137. Rogers GB (2015). Germs and joints: the contribution of the human microbiome to rheumatoid arthritis. Nat Med 21: 839–841.
138. Rojo D, Hevia A, Bargiela R et al (2015). Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases. Sci Rep 5: 8310.
139. Round JL, Mazmanian SK (2010). Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107: 12204–12209.
140. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S (2008). Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181: 2898–2906.
141. Schauber J, Svanholm C, Termén S et al (2003). Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52: 735–741.
142. Scher JU, Abramson SB (2011). The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 7: 569–578.
143. Scher JU, Sczesnak A, Longman RS et al (2013). Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2: e01202.
144. Scher JU, Bretz WA, Abramson SB (2014). Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? Curr Opin Rheumatol 26: 424–429.
145. Schuijs MJ, Willart MA, Vergote K et al (2015). Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349: 1106–1110.
146. Sender R, Fuchs S, Milo R (2016). Revised estimates for the number of human and bacteria cells in the body. bioRxiv doi: 10.1101/036103.
147. Shapira Y, Agmon-Levin N, Shoenfeld Y (2010). Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 6: 468–476.
148. Shiboski C, Shiboski S (2015). ACR-EULAR classification criteria for Sjögren's syndrome: development and validation. Scand J Immunol 81: 330.
149. Shiboski SC, Shiboski CH, Criswell LA et al (2012). American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance Cohort. Arthritis Care Res (Hoboken) 64: 475–487.
150. Shinozaki S, Moriyama M, Hayashida J-N et al (2012). Close association between oral Candida species and oral mucosal disorders in patients with xerostomia. Oral Dis 18: 667–672.
151. Silman AJ, MacGregor AJ, Thomson W et al (1993). Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32: 903–907.
152. de Smit M, Westra J, Vissink A, Doornbos-van der Meer B, Brouwer E, Jan van Winkelhoff A (2012). Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 14: R222.
153. Strachan DP (1989). Hay fever, hygiene, and household size. BMJ 299: 1259–1260.
154. Suzuki T (2013). Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 70: 631–659.
155. Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US (2014). T cell epitope mimicry between Sjögren's syndrome antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 152: 1–9.
156. Talham GL, Jiang H, Bos NA, Cebra J (1999). Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 67: 1992–2000.
157. Thomas T, Gilbert J, Meyer F (2012). Metagenomics – a guide from sampling to data analysis. Microb Inform Exp 2: 3.
158. Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M et al (2013). Novel aspects of Sjögren's syndrome in 2012. BMC Med 11: 93.
159. Triantafyllopoulou A, Moutsopoulos H (2007). Persistent viral infection in primary Sjögren's syndrome: review and perspectives. Clin Rev Allergy Immunol 32: 210–214.
160. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007). The human microbiome project. Nature 449: 804–810.
161. Turnbaugh PJ, Hamady M, Yatsunenko T et al (2009). A core gut microbiome in obese and lean twins. Nature 457: 480–484.
162. Vaishnava S, Yamamoto M, Severson KM et al (2011). The antibacterial lectin RegIIIy promotes the spatial segregation of microbiota and host in the intestine. Science 334: 255–258.
163. Van Praet JT, Donovan E, Vanassche I et al (2015). Commensal microbiota influence systemic autoimmune responses. EMBO J 34: 466–475.
164. Vartoukian SR, Adamowska A, Lawlor M, Moazzez R, Dewhirst FE, Wade WG (2016). In vitro cultivation of “unculturable” oral bacteria, facilitated by community culture and media supplementation with siderophores. PLoS ONE 11: e0146926.
165. Vitali C, Bombardieri S, Jonsson R et al (2002). Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554–558.
166. Vossenkämper A, Blair PA, Safinia N et al (2013). A role for gut-associated lymphoid tissue in shaping the human B cell repertoire. J Exp Med 210: 1665–1674.
167. van der Waaij LA, Harmsen HJM, Madjipour M et al (2005). Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 11: 865–871.
168. Wahren-Herlenius M, Dörner T (2013). Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382: 819–831.
169. Wen L, Ley RE, Volchkov PYV et al (2008). Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109–1113.
170. Whipps JM, Lewis K, Cooke RC (1988). Mycoparasitism and plant disease control. In: Burge MN, Fungi in Biological Control Systems. Manchester University Press, Manchester and New York, pp. 161–187.
171. Wu HJ, Wu E (2012). The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3: 4–14.
172. Wu H, Ivanov II, Darce J et al (2010). Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32: 815–827.
173. Yarza P, Yilmaz P, Pruesse E et al (2014). Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat Rev Microbiol 12: 635–645.
174. Yatsunenko T, Rey FE, Manary MJ et al (2012). Human gut microbiome viewed across age and geography. Nature 486: 222–227.
175. Yurasov S, Hammersen J, Tiller T, Makoto T, Wardemann H (2005). B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann N Y Acad Sci 1062: 165–174.
176. Zarco MF, Vess TJ, Ginsburg GS (2012). The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis 18: 109–120.
177. Zaura E, Keijser BJF, Huse SM, Crielaard W (2009). Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol 9: 259.
178. Zaura E, Brandt BW, Teixeira de Mattos MJ et al (2015). Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. MBio 6: e01693-15.
179. Zhang H, Liao X, Sparks JB, Luo XM (2014). Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol 80: 7551–7560.
180. Zhang J, Guo Z, Xue Z et al (2015a). A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities. ISME J 9: 1979–1990.
181. Zhang X, Zhang D, Jia H et al (2015b). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21: 895–905.
182. Zheng W, Zhang Z, Liu C et al (2015). Metagenomic sequencing reveals altered metabolic pathways in the oral microbiota of sailors during a long sea voyage. Sci Rep 5: 9131.